Fezolinetant

fezolinetant · Astellas Pharma China, Inc.

Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for Fezolinetant, covering 2022-06-15 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Long-term Safety of Fezolinetant Given to Japanese Women Going Through Menopause [Phase 3]